LMO3 and FOS

  • Number of citations of the paper that reports this interaction (PMID 25416956)
  • 0
  • Data Source:
  • BioGRID (two hybrid)

LMO3

FOS

Gene Name LIM domain only 3 (rhombotin-like 2) FBJ murine osteosarcoma viral oncogene homolog
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 33 interactors: AIMP2 BANP CARF CCDC33 CCDC85B CEP170P1 CEP57L1 FAM131C FBLIM1 FOS GABPB1 HNRNPC HNRNPM IKZF1 KCTD1 KXD1 LDB1 LDB2 MBIP MDFI NBPF22P NHLH2 NUTM1 PHC2 RALYL RFX6 RORA SAMD3 SP4 SPERT TAX1BP1 ZBTB43 ZBTB8A 108 interactors: ANP32E APP AQP1 ARFGAP1 ARL6IP4 ATF2 ATF3 ATF4 ATF7 ATP5I BATF BCL3 CABP1 CARM1 CEBPA CEBPE CEBPG CENPO CFAP57 CLU COPS4 CREB5 CREBBP CSNK2A1 CSNK2A2 CYTH4 DDIT3 EEF1D ELK1 ELK4 EPHB2 ETS1 ETS2 GAMT GATA4 GLB1 GNG11 GRHPR GTF2E2 GTF2F1 GTF2F2 HNF1A HSPA1A JUN JUNB JUND KDM2A LMNA LMO3 LUZP4 MAF MAFB MAFF MAP1B MAP3K7 MAPK1 MAPK7 MITF MTERF4 NACA NCOA1 NCOA2 NCOA3 NCOA6 NCOR2 NEFM NELFB NFATC3 NFKB1 OPTN PML POLR2E PRKAA2 PRKACA PSMC5 RB1 RELA RPS6KA1 RPS6KA2 RPS6KA4 RUNX1 RUNX2 SCHIP1 SET SIRT1 SMAD3 SMARCD1 SPI1 SRA1 STAT1 SUMO1 SUMO2 SUMO3 SUMO4 TAF1 TBP TRO TSC22D3 TSPAN2 UBE2D1 UBE2I UBE2L3 UBR1 USF1 USF2 VDR XBP1 ZNF133
Entrez ID 55885 2353
HPRD ID 11832 01275
Ensembl ID ENSG00000048540 ENSG00000170345
Uniprot IDs Q8TAP4 Q9NYC6 B4DQ65 P01100 Q6FG41
PDB IDs 1A02 1FOS 1S9K
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aggressive  aggressiveness  atypical  benign  biosignatures  clinically  constitute  decisions  demand  forty  fourteen  histologically  igf1r  meningioma  meningiomas  metabolic  mostly  nmr  oligonucleotide  otherwise  predominant  proceeds  profiles  recur  recurrence  relevance  subgroup  subgroups  turnover 
ap  argue  capable  dimeric  dimerization  disrupt  glucocorticoid  heterodimerization  homo  homodimerization  hraralpha  hybrid  indirect  interfere  jun  liganded  occurring  promoters  protooncoproteins  ra  raralpha  rars  repress  repression  responsive  retinoic  retinoid  rxr  rxrs 
Tagcloud (Difference) ?
aggressive  aggressiveness  atypical  benign  biosignatures  clinically  constitute  decisions  demand  forty  fourteen  histologically  igf1r  meningioma  meningiomas  metabolic  mostly  nmr  oligonucleotide  otherwise  predominant  proceeds  profiles  recur  recurrence  relevance  subgroup  subgroups  turnover 
ap  argue  capable  dimeric  dimerization  disrupt  glucocorticoid  heterodimerization  homo  homodimerization  hraralpha  hybrid  indirect  interfere  jun  liganded  occurring  promoters  protooncoproteins  ra  raralpha  rars  repress  repression  responsive  retinoic  retinoid  rxr  rxrs 
Tagcloud (Intersection) ?